Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tandem HDCT with Stem Cell Rescue for Metastatic Germ-Cell Tumors
NCT01172912Phase 2Unknown
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Oct 2010
- Primary completion
- Oct 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, etoposide in germ cell tumor (GCT), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Status: unknown.
02
Drugs
carboplatinetoposide
03
Conditions
germ cell tumor (GCT)
Beyond the preview
Go deeper on NCT01172912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01172912.